Omp p6 vaccine for treating and preventing chlamydia infection
AssigneeSanofi Pasteur Limited
InventorsAndrew D. Murdin, Raymond P. Oomen, Joe Wang, Pamela Dunn
Life of this patent
Estimating the term…
Abstract
The present invention provides a vaccine for immunization of a host, including humans, against disease caused by infection by a strain of Chlamydia, specifically C. pneumoniae. The vaccine contains a polypeptide comprising an omp P6 precursor sequence of a strain of C. pneumoniae and variants of the sequence. Modifications are possible within the scope of this invention.
Claims22
A method for preventing or treating Chlamydia infection comprising the step of administering a composition comprising a protein and an adjuvant, wherein the protein comprises the amino acid sequence set forth in SEQ ID No:2.
Dependencies are inferred from the claim text.